Tuniu Discloses Cash Dividend to Holders of ADSs
NANJING, China, April 23, 2026 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today disclosed that the cash dividend of US$1.197 per American depositary shares ("ADSs")...
Now TV presents all award-winning films from the 44th Hong Kong Film Awards
Best Actor and Best Actress winning titles now available (Release schedule attached) HONG KONG, April 23, 2026 /PRNewswire/ -- Now TV presents the largest lineup of award-winning and nominated films from the 44th Hong Kong Film Awards*, delivering a...
CISI Overseas Wealth Management Summit Held in Hong Kong, Spotlighting New Asset Allocation Opportunities amid Global Change
HONG KONG, April 23, 2026 /PRNewswire/ -- Against the backdrop of continued repricing in global capital markets and accelerating technological change, China Industrial Securities International Financial Group Limited ("CISI", stock code: 6058.HK)...
Viettel Post and FedEx Announce Strategic Partnership to Strengthen Cross-Border Logistics in Vietnam
HANOI, Vietnam, April 23, 2026 /PRNewswire/ -- Viettel Post, a member of Viettel Group, and FedEx today announced a strategic partnership in Vietnam aimed at enhancing cross-border logistics capabilities and strengthening the connection between...
Ping An Releases 2025 Sustainability Report, Unveils "SIMPLE" Framework to Drive Long-Term Value Creation
HONG KONG and SHANGHAI, April 23, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or "the Group"; HKEX: 2318/82318; SSE: 601318) released its 2025 Sustainability Report, introducing for the first time its "SIMPLE"...
Mozambique President Visits Zoomlion Smart Industrial City During China State Visit
CHANGSHA, China, April 23, 2026 /PRNewswire/ -- Mozambique's President Daniel Francisco Chapo toured the manufacturing facilities of Chinese heavy equipment maker Zoomlion on April 16, marking the first day of a weeklong state visit to China as the...
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations
SHANGHAI, April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that two latest clinical study results of its Nectin-4-targeting ADC 9MW2821 in...
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
Minjuvi ® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory...